Ye et al. reported that inhibiting the NF-κB pathway with 5,7-dihydroxyflavone could reduce levels of pro-inflammatory cytokines, potentially decreasing susceptibility to AF (55). This evidence concerns the gene NFKB1 and atrial fibrillation.